Abstract
Despite of continuous development of cancer treatment over the past decades, drug resistance is still one of the major hurdles of effective therapy for advanced colorectal cancer (CRC) worldwide and the understanding of its underlying mechanisms remains limited. Data which have emerged suggests that many microRNAs (miRNAs) may contribute to drug resistance in CRC. Major findings on miRNA functions in drug resistance of CRC are systemically reviewed here, with the goal of providing new updates to broaden our comprehension of its mechanisms and evidence to utilize miRNAs as potential therapeutic targets for CRC treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 929-938 |
| Number of pages | 10 |
| Journal | Biological Chemistry |
| Volume | 398 |
| Issue number | 8 |
| DOIs | |
| State | Published - Jul 26 2017 |
Keywords
- apoptosis
- chemoresistance
- chemotherapy
- colorectal cancer
- drug resistance
- miRNAs
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Clinical Biochemistry
Fingerprint Dive into the research topics of 'MicroRNAs are important regulators of drug resistance in colorectal cancer'. Together they form a unique fingerprint.
Cite this
Zhang, Y., & Wang, J. (2017). MicroRNAs are important regulators of drug resistance in colorectal cancer. Biological Chemistry, 398(8), 929-938. https://doi.org/10.1515/hsz-2016-0308